Physician profile
Michael Apostolis
NPI 1770892713
$60,619.22
in general payments reported to CMS, 2019-2025
32 companies · $4,808 in 2025
The $4,808 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $4,439 · 2021: $21K · 2022: $5,546 · 2023: $5,415 · 2024: $6,973 · 2025: $4,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $4,126 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,025.00 |
| Food and Beverage | $4,125.80 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $54,870.43 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Ethicon INC. | $2,563.93 | 2019-2025 | Monarch Platform |
| Glaxosmithkline, LLC. | $589.29 | 2019-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $463.91 | 2019-2025 | Ofev |
| Regeneron Healthcare Solutions, INC. | $307.24 | 2020-2025 | Dupixent |
| Galvanize Therapeutics, INC | $175.25 | 2025 | Aliya System |
| Actelion Pharmaceuticals US, INC. | $137.87 | 2019-2020 | |
| Grifols USA, LLC | $136.29 | 2019-2025 | Prolastin-C Liquid |
| Siemens Medical Solutions USA, INC. | $135.84 | 2025 | Cios Spin |
| Insmed, INC. | $125.33 | 2025 | Brinsupri, Arikayce |
| Merck Sharp & Dohme LLC | $114.66 | 2019-2025 | Winrevair |
| Pulmonx Corporation | $113.76 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Sanofi-Aventis U.S. LLC | $96.50 | 2022 | |
| Mylan Specialty L.P. | $88.59 | 2019-2024 | Yupelri |
| Sunovion Pharmaceuticals INC. | $84.00 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $64.14 | 2025 | Yupelri |
| Genzyme Corporation | $63.01 | 2019-2022 | |
| Harmony Biosciences LLC | $63.00 | 2020-2025 | |
| Verona Pharma, INC. | $50.84 | 2025 | Ohtuvayre |
| Medical Device Business Services, INC. | $50.67 | 2025 | Monarch |
| Jazz Pharmaceuticals INC. | $39.01 | 2019-2025 | |
| United Therapeutics Corporation | $35.95 | 2025 | Tyvaso |
| Circassia INC. | $34.22 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $32.47 | 2025 | Lumryz |
| Novartis Pharmaceuticals Corporation | $29.53 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $28.97 | 2020 | |
| Genentech USA, INC. | $26.87 | 2019 | |
| Baxter Healthcare | $25.00 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Hospital Products INC. | $21.06 | 2020 | |
| Tactile Systems Technology INC | $20.20 | 2025 | Flexitouch Plus, Nimbl |
| Vifor Pharma, INC. | $15.77 | 2024 | Zemaira |
| Philips North America LLC | $15.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Apostolis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.